Ravula; Suchitra

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ravula; Suchitra.The latest application filed is for "monoacylglycerol lipase modulators".

Company Profile

5.8.9

Ravula; Suchitra - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Azabenzimidazoles and their use as AMPA receptor modulators Grant 11,312,712 - Ameriks , et al. April 26, 2	2022-04-26
Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators Grant 10,611,730 - Ameriks , et al.	2020-04-07
Monoacylglycerol Lipase Modulators App 20200102311 - Ameriks; Michael K. ; et al.	2020-04-02
Monoacylglycerol Lipase Modulators App 20200102303 - Ameriks; Michael K. ; et al.	2020-04-02
Indolone compounds and their use as AMPA receptor modulators Grant 10,604,484 - Ameriks , et al.	2020-03-31
Benzimidazolone And Benzothiazolone Compounds And Their Use As Ampa Receptor Modulators App 20190092735 - Ameriks; Michael K. ; et al.	2019-03-28
Fused azaheterocyclic compounds and their use as AMPA receptor modulators Grant 10,155,769 - Ameriks , et al. Dec	2018-12-18
Fused bicylic pyridine compounds and their use as AMPA receptor modulators Grant 10,087,185 - Ameriks , et al. October 2, 2	2018-10-02
Azabenzimidazoles And Their Use As Ampa Receptor Modulators App 20180118740 - Ameriks; Michael K. ; et al.	2018-05-03
Indolone Compounds And Their Use As Ampa Receptor Modulators App 20180118683 - Ameriks; Michael K. ; et al.	2018-05-03
Fused Azaheterocyclic Compounds And Their Use As Ampa Receptor Modulators App 20180111942 - Ameriks; Michael K. ; et al.	2018-04-26
Fused Bicylic Pyridine Compounds And Their Use As Ampa Receptor Modulators App 20180111933 - Ameriks; Michael K. ; et al.	2018-04-26
Pyrazolopyrimidines and related heterocycles as CK2 inhibitors Grant 9,303,033 - Haddach , et al. April 5, 2	2016-04-05
Pyrazolopyrimidines And Related Heterocycles As Ck2 Inhibitors App 20140094448 - Haddach; Mustapha ; et al.	2014-04-03
Pyrazolopyrimidines and related heterocycles as CK2 inhibitors Grant 8,575,177 - Haddach , et al. November 5, 2	2013-11-05
Pyrazolopyrimidines And Related Heterocycles As Ck2 Inhibitors App 20110152240 - Haddach; Mustapha ; et al.	2011-06-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.